Cambridge Network & MedImmune event: The necessity of digital health in treating respiratory diseases

Cambridge Network & MedImmune event: The necessity of digital health in treating respiratory diseases

This event will explore the necessity of digital health for respiratory diseases. With digital technologies set to disrupt the healthcare sector in the future, Medimmune recognises this opportunity, and is looking to position itself as a leader in digital adoption in their pipeline and beyond.

Dates 17 Apr 2018 - This event is in the past.
Opening times 1.45pm to 6.30pm
Venue Hauser Forum, The Entrepreneurship Centre, 3 Charles Babbage Road, CB3 0GT
Organiser name Louise Rushworth
01223 760102

Event details:

Cambridge Network & MedImmune event: The necessity of digital health in treating respiratory diseases

Focusing on respiratory disease this event will explore where digital health could have an impact in generating novel endpoints that give greater insight into disease progression and management. The keynote talk will be given by arm on Enabling Digital Health, with supporting talks from Owlstone Medical, Mologic and Pneumacare along with the finalists from the Digital Health Challenge.


Have you developed - or are you looking to create - a healthcare solution based on digital technology? If so, you stand the chance of winning £20,000 and mentoring opportunities from MedImmune - winners to be announced at this event. Details can be found in the attached flyer (see 'related document' near the Book Now button, above) or here. The Tech Challenge is now closed for entries.



Digital Health MedImmune




Welcome and introduction

Dr Jane Osbourn, Vice President, R&D, MedImmune

Jane Osbourn, MedImmune


Dr Donna Finch, Principal Scientist and Team Leader; Respiratory, Inflammation and Autoimmunity (RIA), MedImmune



Keynote talk: Enabling Digital Health - ARM

Mobile technology is fully integrated into our daily lives; so how do we translate this into smart digital devices for proactive healthcare and pharmaceutical advancement? This presentation will challenge and discuss the barriers that exist to realizing the full benefits of patient connectivity at scale, and show how digital health will impact our not-so-distant future

Speaker: Peter Ferguson, Director of Healthcare Technologies



Breath Biopsy - VOCs biomarkers in early detection and precision medicine

Every time you breathe out there are thousand of chemicals on your breath called volatile organic compounds or VOCs. Some of these VOCs are biomarkers of disease in everything ranging from cancer to inflammatory and infectious disease. We'll discuss how Breath Biopsy technology can be used in early detection and precision medicine applications.

Speaker: Billy Boyle, Owlstone

Billy Boyle, Owlstone Medical


The message in the bottle…….of urine!

Most of the biomarkers we find in urine originate in the lungs and are processed through the kidneys. Consequently, we can learn much about what’s going in the lungs and how the kidneys are responding to the presence of high levels of inflammatory mediators (including proteases) escaping from the lung into the blood.  Mologic is busy developing ways to accurately determine the biomarker profiles by simple, patient-friendly technology, and to translate the resultant digital health data into simple diagnostic conclusions and triggering of interventions.

Speaker: Prof Paul Davis, Chief Scientific Officer


3.30pm Pneumacare

PneumaCare’s mission is to provide revolutionary imaging technologies that increase efficient and effective patient care with a vision of becoming the market leader in non-contact, non-invasive imaging technology.
PneumaCare is a Cambridgeshire (UK)-based company providing clinicians with unique non-invasive ways of observing active, real-time regional respiratory function via chest wall movement. It provides the capability for clinicians to assess respiratory function in all patients including previous inaccessible groups, whether young or old, conscious or unconscious, sitting or lying down; and its use does not require any contact or direct interaction with the patient.

Speaker: Paul Reynard, COO




The Digital Health Technology Challenge for Entrepreneurs

These entrepreneurs have a passion for creating novel digital solutions to solve drug development’s most difficult problems. Five finalists will have a chance to win the grand prize by presenting to a panel of prominent industry funding experts and executives:

  • Jane Osbourn, Vice President, R&D, MedImmune
  • Andy Williams, Vice President, Strategy and Operations, AstraZeneca
  • Debu Purkayastha, Managing Partner, 3rd Eye Capital
  • Andrew Chapman, Digital Health Sector Lead, Digicatapult

Applications for these awards are now closed.


Q&A for the speakers


Closing remarks and the results of the Tech Challenge announced


Networking over light refreshments



To attend:  Attendance is free of charge. Please set up an account by clicking on 'Register' on the grey navigation bar above (or log in if you already have an account) before returning to this page and clicking Book Now!

Mailing list: If you would like to hear about other events we run for both members/non-members of Cambridge Network please sign up. We try not to over-mail you, and you can unsubscribe at any time.

Cambridge Network would like to thank MedImmune for their help in setting up this event.



Cambridge Network Limited

Cambridge Network is a membership organisation based in the vibrant high technology cluster of Cambridge, UK. We bring people together - from business and academia - to meet each other and share ideas, encouraging collaboration and partnership for shared success.

Cambridge Network Limited directory information